The three year grant, worth over £140,000, forms part of over £4.2 million invested in research by Campaign in the last year.
Dr Martin will study a group of molecules called redox proteins which are thought to help breast cancer cells survive. By examining 2,000 breast cancer samples he hopes to discover whether these proteins play a role in the development of breast cancer and whether they are resistant to breast cancer treatments such as chemotherapy and radiotherapy.
Dr Martin said “The results of this project may help clinicians to select the most appropriate treatments for patients and the development of breast cancer treatments in the future.”
Pamela Goldberg, Chief Executive, Breast Cancer Campaign said “Thanks to real progress in breast cancer research we have seen significant improvements in diagnosis, treatment and survival. Breast cancer research is saving lives and our mission is to beat breast cancer by funding world class research projects such as Dr Martin’s to keep up the momentum of bringing us closer to a cure.”
Emma Thorne | alfa
Tracking movement of immune cells identifies key first steps in inflammatory arthritis
23.01.2017 | Massachusetts General Hospital
Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
23.01.2017 | Health and Medicine
23.01.2017 | Physics and Astronomy
23.01.2017 | Process Engineering